<DOC>
	<DOCNO>NCT01759108</DOCNO>
	<brief_summary>Xerostomia major distress symptom Sjőgren 's syndrome ( SS ) . Preclinical clinical study demonstrate increase saliva volume follow rebamipide administration.We thus hypothesize rebamipide may efficacious treatment dry mouth symptom related Sjőgren 's syndrome.We recruit SS patient randomize placebo-controlled trial 12 week . The main outcome measure concern u patient-assessed improvement dry mouth symptom increase salivary secretion Safety efficacy assess visit .</brief_summary>
	<brief_title>Rebamipide Treatment Xerostomia sjögren Syndrome</brief_title>
	<detailed_description>Xerostomia major distress symptom Sjőgren 's syndrome ( SS ) . Persistent dryness mouth cause oral pain , discomfort significantly interfere quality life . Rebamipide , addition gastro-protective effect display various anti-inflammatory action include inhibition neutrophilic leukocyte activation . Preclinical clinical study demonstrate increase saliva volume follow rebamipide administration . The aim present study ass efficacy rebamipide treatment dry mouth symptom related Sjőgren 's syndrome . Methods : Fifty-five patient American European Consensus Criteria Group ( AECG ) -based diagnosis SS participate randomize placebo-controlled trial . Inclusion criterion include SS patient dry mouth symptom . Patients dry mouth due condition exclude . Patients randomize 1:1 receive either 300mg/d ( 100mg x3/day ) rebamipide placebo 12 week together usual therapy . Outcome measure include patient-assessed improvement dry mouth symptom increase salivary secretion ( evaluation unstimulated saliva ; questionnaire include visual analogue scale ( VAS ) Sicca-syndrome VAS 0-100mm ) . Subjective objective finding dry mouth record baseline , two , four , six , eight , ten twelve week . Safety efficacy assess visit .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>SS patient dry mouth symptom Patients dry mouth due condition</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>xerostomia</keyword>
	<keyword>rebamipide</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>